FDA Drug Application (204914) for LAMIVUDINE; ZIDOVUDINE by MYLAN LABS

Back to FDA Applications sponsored by MYLAN LABS

Application Number204914
Product Number001
FormTABLET; ORAL SUSPENSION
Dosage30MG; 60MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLAMIVUDINE; ZIDOVUDINE
Active IngredientLAMIVUDINE; ZIDOVUDINE

Active IngredientCount
List of drugs with Active Ingredient EFAVIRENZ11
List of drugs with Active Ingredient LAMIVUDINE39
List of drugs with Active Ingredient ZIDOVUDINE17


Back to FDA Applications sponsored by MYLAN LABS